The Saliva of Probands Sucking an Iota-Carrageenan Containing Lozenge Inhibits Viral Binding and Replication of the Most Predominant Common Cold Viruses and SARS-CoV-2

References

• Denny FW Jr. The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med. 1995;152(4 Pt 2):S4–S12. doi:10.1164/ajrccm/152.4_Pt_2.S4
   PubMed Web of Science ®Google Scholar
• Snell NJ. New treatments for viral respiratory tract infections – opportunities and problems. J Antimicrob Chemother. 2001;47(3):251–259. doi:10.1093/jac/47.3.251
   PubMed Web of Science ®Google Scholar
• Eccles R, Meier C, Jawad M, Weinmüllner R, Grassauer A, Prieschl-Grassauer E. Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold. Respir Res. 2010;11(1):108. doi:10.1186/1465-9921-11-108
   PubMed Web of Science ®Google Scholar
• Fazekas T, Eickhoff P, Pruckner N, et al. Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold. BMC Complement Altern Med. 2012;12(1):147. doi:10.1186/1472-6882-12-147
   PubMed Web of Science ®Google Scholar
• Koenighofer M, Lion T, Bodenteich A, et al. Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials. Multidiscip Respir Med. 2014;9(1):57. doi:10.1186/2049-6958-9-57
   PubMedGoogle Scholar
• Ludwig M, Enzenhofer E, Schneider S, et al. Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial. Respir Res. 2013;14(1):124. doi:10.1186/1465-9921-14-124
   PubMed Web of Science ®Google Scholar
• Eccles R, Winther B, Johnston SL, Robinson P, Trampisch M, Koelsch S. Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial. Respir Res. 2015;16(1):121. doi:10.1186/s12931-015-0281-8
   PubMed Web of Science ®Google Scholar
• Figueroa JM, Lombardo M, Dogliotti A, et al. Efficacy of a nasal spray containing iota-carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease a pragmatic multicenter, randomized, double-blind, placebo-controlled trial (CARR-COV-02). medRxiv. 2021. doi:10.1101/2021.04.13.21255409 
   Google Scholar
• Grassauer A, Weinmuellner R, Meier C, Pretsch A, Prieschl-Grassauer E, Unger H. Iota-carrageenan is a potent inhibitor of rhinovirus infection. Virol J. 2008;5(1):107. doi:10.1186/1743-422X-5-107
   PubMed Web of Science ®Google Scholar
• Leibbrandt A, Meier C, König-Schuster M, et al. Iota-carrageenan is a potent inhibitor of influenza A virus infection. PLoS One. 2010;5(12):e14320. doi:10.1371/journal.pone.0014320
   PubMed Web of Science ®Google Scholar
• Morokutti-Kurz M, Graf C, Prieschl-Grassauer E. Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat. Int J Gen Med. 2017;10:53–60. doi:10.2147/IJGM.S120665
   PubMed Web of Science ®Google Scholar
• Morokutti-Kurz M, Fröba M, Graf P, et al. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro. PLoS One. 2021;16(2):e0237480. doi:10.1371/journal.pone.0237480
   PubMed Web of Science ®Google Scholar
• Yasir M, Goyal A, Bansal P, Sonthalia S, eds. StatPearls [Internet]. StatPearls Publishing; 2020.
   Google Scholar
• Bansal S, Jonsson CB, Taylor SL, et al. Iota-carrageenan and xylitol inhibit SARS-CoV-2 in cell culture. bioRxiv. 2020. doi:10.1101/2020.08.19.225854
   PubMedGoogle Scholar
• Charlton CL, Babady E, Ginocchio CC, et al. Practical guidance for clinical microbiology laboratories: viruses causing acute respiratory tract infections. Clin Microbiol Rev. 2019;32(1);e00042–e00118. doi:10.1128/CMR.00042-18
   PubMed Web of Science ®Google Scholar
• Schütz D, Conzelmann C, Fois G, et al. Carrageenan containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol. 2021;320(5):L750–L756. doi:10.1152/ajplung.00552.2020
   PubMed Web of Science ®Google Scholar
• Graf C, Bernkop-Schnürch A, Egyed A, Koller C, Prieschl-Grassauer E, Morokutti-Kurz M. Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis. Int J Gen Med. 2018;11:275–283. doi:10.2147/IJGM.S167123
   PubMed Web of Science ®Google Scholar
• Große M, Ruetalo N, Businger R, et al. Evidence that quinine exhibits antiviral activity against SARS-CoV-2 infection in vitro. Preprints. 2020;2020070102.
   Google Scholar
• Eccles R. Iota-carrageenan as an antiviral treatment for the common cold. Open Virol J. 2020;14(1):9–15. doi:10.2174/1874357902014010009
   Google Scholar
• World Health Organization.WHO Manual on Animal Influenza Diagnosis and Surveillance. Available from: https://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf. Accessed August 31, 2021.
   Google Scholar
• Hemilä H, Chalker E. Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: re-analysis of randomized trial data. Pharmacol Res Perspect. 2020;9(4):e00810
   Web of Science ®Google Scholar
• Jang Y, Shin H, Lee MK, et al. Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2. Sci Rep. 2021;11(1):821. doi:10.1038/s41598-020-80896-9
   PubMed Web of Science ®Google Scholar
• Huijghebaert S, Vanham G, van Winckel M, Allegaert K. Does trypsin oral spray (Viruprotect®/ ColdZyme®) protect against COVID-19 and common colds or induce mutation? Caveats in medical device regulations in the European union. Int J Environ Res Public Health. 2021;18(10):5066. doi:10.3390/ijerph18105066
   PubMed Web of Science ®Google Scholar
• Collins LM, Dawes C. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J Dent Res. 1987;66(8):1300–1302. doi:10.1177/00220345870660080201
   PubMed Web of Science ®Google Scholar